China: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in China

In 2021, the Chinese medicaments containing insulin market decreased by -4.6% to $X, falling for the third year in a row after three years of growth. Overall, consumption showed a sharp shrinkage. Over the period under review, the market reached the maximum level at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in China

In value terms, medicaments containing insulin production fell slightly to $X in 2021 estimated in export price. In general, production, however, saw a relatively flat trend pattern. The growth pace was the most rapid in 2018 when the production volume increased by 3.9% against the previous year. Over the period under review, production attained the peak level at $X in 2020, and then reduced modestly in the following year.

Medicaments Containing Insulin Exports

Exports from China

For the seventh consecutive year, China recorded decline in overseas shipments of medicaments containing insulin but not antibiotics, which decreased by -53.4% to X kg in 2021. Overall, exports showed a deep downturn. The most prominent rate of growth was recorded in 2014 with an increase of 1,213%. As a result, the exports reached the peak of X tons. From 2015 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, medicaments containing insulin exports reduced remarkably to $X in 2021. Over the period under review, exports saw a deep reduction. The pace of growth was the most pronounced in 2014 with an increase of 932%. As a result, the exports reached the peak of $X. From 2015 to 2021, the growth of the exports remained at a lower figure.

Exports by Country

Nigeria (X kg) was the main destination for medicaments containing insulin exports from China, with a 79% share of total exports. Moreover, medicaments containing insulin exports to Nigeria exceeded the volume sent to the second major destination, Sudan (X kg), fourfold.

From 2012 to 2021, the average annual rate of growth in terms of volume to Nigeria totaled -15.8%.

In value terms, Sudan ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from China, comprising 77% of total exports. The second position in the ranking was taken by Nigeria ($X), with a 3.3% share of total exports.

From 2012 to 2021, the average annual growth rate of value to Sudan totaled +14.1%.

Export Prices by Country

In 2021, the average medicaments containing insulin export price amounted to $X per ton, increasing by 21% against the previous year. Over the period under review, export price indicated a temperate increase from 2012 to 2021: its price increased at an average annual rate of +2.1% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing insulin export price increased by +114.5% against 2014 indices. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major foreign markets. In 2021, amid the top suppliers, the country with the highest price was Sudan ($X per ton), while the average price for exports to Nigeria amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Sudan (+2.3%).

Medicaments Containing Insulin Imports

Imports into China

In 2021, purchases abroad of medicaments containing insulin but not antibiotics decreased by -19.6% to X kg, falling for the third consecutive year after three years of growth. Overall, imports faced a sharp curtailment. The most prominent rate of growth was recorded in 2018 when imports increased by 2,127%. Over the period under review, imports attained the peak figure at X tons in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports rose to $X in 2021. In general, imports saw a significant curtailment. The pace of growth was the most pronounced in 2018 with an increase of 747%. Imports peaked at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

Imports by Country

In 2021, the United States (X kg) was the main medicaments containing insulin supplier to China, with a approx. 99% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from the United States amounted to -47.3%.

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to China.

From 2012 to 2021, the average annual rate of growth in terms of value from the United States totaled -54.7%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, jumping by 29% against the previous year. Over the period under review, the import price, however, saw a abrupt decline. The pace of growth appeared the most rapid in 2019 when the average import price increased by 29% against the previous year. Over the period under review, average import prices reached the peak figure at $X per ton in 2014; however, from 2015 to 2021, import prices stood at a somewhat lower figure.

As there is only one major supplying country, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to -13.9% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :